Opus Genetics reports gene therapy trial data for two eye diseases

Go back to Opus Genetics reports gene therapy trial data for two eye diseases
Diversified Corporate Resources, Inc. (NASDAQ: IRD) Delayed: 3.70 -0.12 (3.14%)
Previous Close $3.82    52 Week High $0.02 
Open $3.79    52 Week Low $0.02 
Day High $3.83    P/E N/A 
Day Low $3.67    EPS $0.00 
Volume 117,189